| Model Number |
DTPB2D4 |
| Medical Device Problem Codes |
Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); Device Sensing Problem (2917)
|
| Health Effect - Clinical Codes |
Anxiety (2328); Sleep Dysfunction (2517); Shock from Patient Lead(s) (3162)
|
| Date of Event |
08/30/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient received inappropriate anti-tachycardia pacing (atp) and high-voltage therapy for supra ventricular tachycardia (svt) versus atrial fibrillation (af) with rapid ventricular response that the cardiac resynchronization therapy defibrillator (crt-d) classified ventricular tachycardia (vt)/ventricular fibrillation (vf) and the patient was hospitalized.Medication management was performed for the patient's underlying condition and arrhythmia.Additionally, it was reported that the patient had increased anxiety with difficulty sleeping since the shocks.The device remains in use.The patient is a participant in a clinical study.No further patient complications have been reported as a result of this event.
|
| |
|
Search Alerts/Recalls
|